Interleukin-1b-converting enzyme (ICE)/ced-3 family proteases play key roles in apoptosis. However, cellular substrates for ICE family proteases involved in apoptosis are not well understood. We previously showed that actin is cleaved in vitro by an ICE family protease, distinct from ICE itself, which is activated during VP-16-induced apoptosis. In this report, we demonstrate that the actincleaving ICE-family protease in the apoptotic cell extract is the activated CPP-32/apopain. CPP-32 eectively cleaves actin protein to 15 kDa and 31 kDa fragments. Studies with an antibody raised against GlyGln-Val-Ile-Thr peptide, the N-terminal sequence of the cleaved 15 kDa actin fragment, showed that actin is also cleaved in vivo during the development of apoptosis. Moreover, Benzyloxycarbonyl-Glu-Val-Asp-CH 2 OC(O)-2,6,-dichlorobenzene (Z-EVD-CH 2 -DCB), a selective inhibitor of CPP-32(-like) protease, eciently inhibited the cleavage of actin and the apoptosis of VP-16-treated U937 cells. Our present results indicate that actin is the substrate of CPP-32/apopain(-like) protease both in vitro and in vivo and suggest the role of actin in the control of cell growth and apoptosis.
Introduction
Apoptosis is a physiological cell death characterized by membrane blebbing, chromatin condensation and DNA fragmentation resulting in an oligonucleosomal ladder (Vaux and Strasser, 1996) . Although the mechanisms of apoptosis are not fully understood, increasing evidence has indicated the involvement of interleukin-1b-converting enzyme (ICE)/ced-3 family proteases in the common pathway of apoptotic cell death. ICE is a cysteine protease identi®ed as a mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 (Yuan et al., 1993) . In addition to ICE, several other ICE/ced-3 family protease genes (Ich-1/Nedd-2, CPP-32/YAMA/apopain, TX/ICE rel -II/Ich-2, ICE rel -III/TY, Mch-2) have been isolated (Kumar et al., 1994; Fernandes-Alnemri et al., 1994 Nicholson et al., 1995; Faucheu et al., 1995; . These proteases are thought to be potentially positive regulators of apoptosis, because apoptosis was induced by the overexpression of these protease genes and was inhibited by ICE/ced-3 protease-speci®c inhibitors (Gagliardini et al., 1994; Enari et al., 1995; Mashima et al., 1995a; Los et al., 1995; Boudreau et al., 1995; Miura et al., 1995) . As of now, the importance of ICE/ced-3 proteases in the apoptotic processes has been accepted, but the biochemical events downstream of these proteases are unknown.
We previously showed that actin is a substrate of ICE and an ICE-like protease activated in VP-16-treated U937 cells when actin was incubated with the proteases in vitro (Mashima et al., 1995b) . Since ICE itself is not activated in VP-16-treated U937 cells (Mashima et al., 1995b; Noguchi et al., 1996) , an ICElike protease, distinct from ICE, is responsible for the actin-cleavage activity. In this report, we demonstrate that the actin-cleaving ICE-like protease is the activated form of CPP-32/apopain. We also demonstrate that the actin-cleavage occurs in vivo in U937 cells during apoptosis. Actin-cleavage and apoptosis were both inhibited by Benzyloxycarbonyl-Glu-ValAsp-CH 2 OC(O)-2,6,-dichlorobenzene (Z-EVD-CH 2 -DCB), a potent inhibitor of CPP-32(-like) protease. Our present results indicate that actin is the speci®c substrate of CPP-32/apopain(-like) protease in vitro and in vivo and suggest the role of actin in the control of cell growth and apoptosis.
Results

Identi®cation of CPP-32/apopain as the actin cleavage protease
We previously showed that an actin-cleavage activity (ACA), inhibitable by ICE/ced-3 protease inhibitors, is activated in human myeloid leukemia U937 cells during VP-16-induced apoptosis. This proteolytic activity was selective for actin compared to the IL-1b precursor, which contrasted with the proteolytic activity of ICE (Mashima et al., 1995b) . As shown in Figure 1a , the ACA is also activated in U937 cells by treatment with camptothecin or tumor necrosis factor-a (TNF-a). Treatment of the cells with other antitumor-agents, such as ara-C, cisplatin, or mitomycin C equally activate the ACA in U937 cells (data not shown). As ICE is not activated in apoptotic U937 cells, ICE itself is not responsible for the ACA (Mashima et al., 1995b; Noguchi et al., 1996) . To identify an ICE family protease responsible for ACA, we examined the correlation between the activation of ACA and that of CPP-32/apopain, because CPP-32, a member of ICE/ced-3 family protease, is activated during VP-16-and Fas-induced U937 apoptosis (Noguchi et al., 1996) . As shown in Figure 1a and b, processing of CPP-32 to the active p17/p12 form by the treatment with VP-16, camptothecin and TNF-a accompanied the activation of ACA in U937 cells. We next examined the inhibitory eect of ICE-and CPP-32-selective inhibitors on the actin-cleavage activity. Z-EVD-CH 2 -DCB, a selective inhibitor of CPP-32(-like) protease, inhibits CPP-32 activity at least tenfold more strongly than Benzyloxycarbonyl-Val-Ala-Asp-CH 2 OC(O)-2,6,-dichlorobenzene (Z-VAD-CH 2 -DCB), a selective inhibitor of ICE(-like) protease (unpublished data). Figure  2 shows that ACA is preferentially inhibited by Z-EVD-CH 2 -DCB as compared to Z-VAD-CH 2 -DCB suggesting that ACA is mainly contributed by CPP-32(-like) protease.
To demonstrate convincingly that ACA in VP-16-treated U937 cytosol was CPP-32, the CPP-32 was immunoprecipitated and the actin-cleavage activity was measured in the supernatant and pellet. When CPP-32 was immunoadsorbed from VP-16-treated U937 cell lysate, the active p17 fragment of CPP-32 disappeared and the actin-cleavage activity was reduced to 17% of the control (Figure 3 supernatant, lane 2) . Another ICE family protease, Ich-1L, was not immunoadsorbed by the anti-CPP-32 antibody. Furthermore, the immunoprecipitated CPP-32 eectively cleaved actin to generate 15 kDa and 31 kDa fragments when the precipitated CPP-32 from VP-16-treated U937 lysate was incubated with puri®ed actin (Figure 3 pellet, lane 2). These results indicate that the actin-cleavage activity in VP-16-treated U937 lysate is mainly due to activated CPP-32.
Cleavage of actin by CPP-32 and ICE
We next compared actin cleavage by CPP-32 and by ICE. As shown in Figure 4 , recombinant CPP-32 , camptothecin, and TNF-a. U937 cells were left untreated (control) or continuously treated with 10 mg/ml of VP-16 for 4 h, with 10 mg/ ml of camptothecin (CPT) for 4 h, or with 1 ng/ml of TNF-a and 1 mg/ml of cycloheximide simultaneously (TNF) for 4 h. The drug-treated cell lysates (20 mg protein/sample) were prepared as described (Mashima et al., 1995b) and incubated with biotinylated actin at 378C for 2 h in ICE assay buer. The cleavage of actin was detected as described in Materials and methods. (b) Proteolytic activation of CPP-32 in U937 cells by the treatment with VP-16, camptothecin, and TNF-a. U937 cells were treated with VP-16, CPT, and TNF-a+cycloheximide as described above, and the proteolytic activation of CPP-32 to a p17 fragment was detected by Western blotting using anti-CPP-32 antibody as described in Materials and methods Each immunoprecipitated fraction was incubated with biotinylated actin and the cleavage of actin was detected as described in Materials and methods cleaved actin but not the IL-1b precursor, whereas recombinant ICE cleaved the IL-1b precursor efficiently. Both CPP-32 and ICE cleaved actin to generate a 15 kDa fragment. We previously showed that an ICE-like protease in VP-16-treated U937 lysate cleaves actin between Asp 244 and Gly 245 to generate a 15 kDa fragment whose N-terminus sequence is Gly-Gln-ValIle-Thr (GQVIT) (Mashima et al., 1995b) . We generated an antibody raised against a GQVIT synthetic peptide and tested whether this antibody recognizes the ICE-or CPP-32-cleaved 15 kDa fragment of actin. As shown in Figure 5a , the anti-GQVIT antibody recognized both ICE-and CPP-32-cleaved 15 kDa actin fragments as well as that cleaved by the protease in VP-16-treated U937 lysate. The antibody recognized the 15 kDa fragment but not the 45 kDa uncleaved actin protein (data not shown), and the recognition of 15 kDa fragment by the antibody was eectively competed by an excess amount of GQVITC peptide (Figure 5a , +GQVIT), indicating that the antibody speci®cally recognizes the N-terminal GQVIT sequence of the cleaved 15 kDa fragment but not the uncleaved actin protein. These results showed that the 15 kDa fragments cleaved by ICE, CPP-32, and VP-16-treated U937 lysate have the same Nterminus GQVIT and that both ICE and CPP-32 cleave actin between Asp 244 and Gly 245 as well as the protease in VP-16-treated U937 lysate.
While CPP-32 cleaved actin to generate 31 kDa and 15 kDa fragments as has been observed with apoptotic U937 lysates, ICE cleaved actin to generate &40, 29, and 15 kDa fragments (Figure 4 ). These results indicated that CPP-32, as well as the protease in VP-16-treated U937 lysate, cleaves actin at one site (between Asp 244 and Gly
245
) to generate two cleaved fragments (31 kDa and 15 kDa), but ICE further cleaves actin at an additional site between Asp 11 and Asn 12 as reported previously (Kayalar et al., 1996) (Figure 5b ).
Cleavage of actin in vivo
Actin was shown to be the selective substrate of CPP-32 and ICE in vitro, however, there has not been any evidence for the cleavage of actin by CPP-32 or ICE in vivo. We further tested whether cellular actin is actually cleaved in vivo during the development of apoptosis of U937 cells. As shown in Figure 6 , when U937 cells were treated with VP-16, the apoptotic DNA degradation to an oligonucleosomal ladder occurred. The anti-GQVIT antibody detected the 15 kDa actin fragment in apoptotic U937 cells, indicating that actin is actually cleaved to 15 kDa fragment in apoptotic U937 cells. The cleavage of actin to the 15 kDa fragment occurred during the development of apoptosis in a time dependent manner (data not shown). Another actinderected antibody, C4, further detected the 31 kDa actin fragment in VP-16-treated U937 cells but not in non-treated cells (data not shown). The induction of apoptotic DNA degradation and the actin cleavage in vivo were both inhibited by Z-EVD-CH 2 -DCB, an inhibitor of CPP-32(-like) protease (Figure 6 ). These results indicated that the actin cleavage by CPP-32 (-like) protease actually occurs in vivo during VP-16-induced apoptotic cell death.
Discussion
Activation of ICE family proteases plays a key role in apoptosis, and, among them, CPP-32/apopain has been recognized as a common mediator of apoptosis Noguchi et al., 1996; . However, the subsequent mechanisms resulting in apoptosis is largely unknown. Cleavage of poly(ADP-ribose) polymerase (PARP) by CPP-32(-like) proteases is a generally observed event during apoptosis (Kaufmann et al., 1993; . Since poly(ADPribosyl)ation is implicated in many fundamental processes, such as DNA repair, chromatin stability and cell proliferation, one can assume PARP cleavage is a key event for apoptosis. However, the fact that PARP-de®cient mice have only a mild phenotype (Wang et al., 1995) suggests that PARP cleavage is not indispensable for apoptotic cell death during embryogenic development. Other substrates cleaved by ICE family proteases could be involved in apoptosis. Recently several proteins such as U1-70K, DNA-PK, and SREBP have been reported to be cleaved by CPP-32 , but their signi®cance in apoptosis is not entirely elucidated. In this report we showed that actin is the substrate of the cell death protease CPP-32. Moreover, we also showed for the ®rst time that actin cleavage by ICE family proteases actually occurs in the cells during apoptosis. We have shown that the active form of CPP-32 can cleave actin in vitro. Also, the cleavage of actin in apoptotic U937 cells is mainly due to CPP-32, since (1) CPP-32 is activated during the apoptosis of U937 cells, (2) the actin-cleavage activity in apoptotic U937 cell extract was almost completely immunoadsorbed with anti-CPP-32 antibody, and (3) the actin-cleavage in U937 cells was completely suppressed by Z-EVD-CH 2 -DCB, a selective inhibitor of CPP-32(-like) protease. In the CPP-32-depleted lysate, the actin-cleavage activity weakly remained (Figure 3 ). This activity could be due to another CPP-32-like proteases, since the CPP-32-depleted lysate still contained a signi®cant amount of the cleavage activity of Asp-Glu-Val-Asp-4-methylcoumaryl-7-amide (DEVD-MCA), a¯uorogenic substrate of CPP-32(-like) protease (data not shown). ICE can also cleave actin as reported previously (Kayalar et al., 1996) , but ICE is not activated in U937 cells during apoptosis (Mashima et al., 1995b; Noguchi et al., 1996) . In addition, cleavage sites of actin by ICE are dierent from that by CPP-32 and apoptotic U937 lysates. Moreover, the actin-cleavage activity was also activated in apoptotic ovarian carcinoma cells and the activity was nearly completely immunoadsorbed by anti-CPP-32 antibody (unpublished observation). These results indicate that CPP-32 but not ICE is responsible for actin cleavage in vivo. ) to generate &40, 29 and 15 kDa fragments (Kayalar et al., 1996) , while CPP-32 cleaves actin at one site (Asp Cleavage of actin during apoptosis and inhibition of actin-cleavage by an inhibitor of CPP-32 in vivo. U937 cells were either left untreated (no treat) or treated with 10 mg/ml of VP-16 (VP), 10 mg/ml of VP-16 and 100 mg/ml of Z-EVD-CH 2 -DCB (VP+EVD), or 100 mg/ml of Z-EVD-CH 2 -DCB (EVD) for 16 h. Each cell lysate was prepared and the cleavage of actin was detected by Western blotting using anti-GQVITC polyclonal antibody (a) as described in Materials and methods. Simultaneously, cellular DNA was extracted and the DNA fragmentation was analysed (b) as described previously (Mashima et al., 1995a) At present, the role of actin-cleavage during apoptosis is not clear. The actin-cleavage by CPP-32 (-like) protease could cause damage to the cells, since actin is one of the major proteins in the cell and has various roles in cellular activities and morphogenesis (Kabsch et al., 1992; Satterwhite and Pollard, 1992) . It is possible that actin cleavage is involved in morphological changes characteristic of apoptosis. Regarding the nature of actin as an inhibitor of DNaseI, a candidate endonuclease responsible for the apoptotic DNA fragmentation (Peitsch et al., 1993) , the recent ®nding that the actin cleaved by ICE loses the ability to inhibit the nuclease (Kayalar et al., 1996) suggests the importance of actincleavage in the nuclear apoptosis. In addition, it should be noted that the alterations of actin and the actinrelated proteins have been reported to be implicated in tumorgenesis (Kakunaga et al., 1984; Antecol et al., 1986; McWhirter and Wang, 1993) . Vandekerckhove et al. showed that a point mutation in actin gene could cause transformation of a human ®broblast cell line (Vandekerckhove et al., 1980) . Interestingly, the mutated site of the actin in the transformed cell line (Gly?Asp) corresponds to the cleavage site of actin by CPP-32(-like) protease during apoptosis. This change could aect the cleavability by the protease, since CPP-32(-like) protease preferentially cleaves Asp-X, where X is a small amino acid like Gly and Ser. These observations could suggest that actin is involved in tumorgenesis by controlling the cellular sensitivity to apoptosis. Further studies are needed to elucidate the signi®cance of actin as a substrate of CPP-32(-like) protease.
Materials and methods
Cell lines and cell culture
A human myeloid leukemia U937 cell line was obtained from the Japanese Cancer Research Resources Bank, Tokyo, Japan. Cells were maintained in RPMI-1640 medium (Nissui Co, Ltd, Tokyo, Japan), supplemented with 10% heat-inactivated fetal bovine serum and 100 mg/ ml of kanamycin in a humidi®ed atmosphere of 5% CO 2 and 95% air.
Chemicals and proteins
Z-VAD-CH 2 -DCB was synthesized, as described (Dolle et al., 1994) . Z-EVD-CH 2 -DCB was synthesized by basically the same chemical procedure as Z-VAD-CH 2 -DCB. Rabbit actin was purchased from Sigma, St Louis, MO, USA. Recombinant human Interleukin-1b precursor and antihuman IL-1b (rabbit antiserum) were obtained from Cistron Biotechnology, Pine Brook, NJ, USA. Antihuman CPP-32 monoclonal antibody was from Transduction Laboratories, Lexington, KY, USA. Anti-human Ich-1L was obtained from Santa Cruz Biotechnology, Inc, Santa Cruz, Cal, USA. Anti-actin monoclonal antibody (C4) was from Cosmo Bio Co Ltd, Tokyo, Japan. Recombinant ICE and CPP-32/apopain were prepared by expressing their constitutive subunits separately in E. coli then re-folding the active enzyme as described previously (Thornberry et al., 1992; Rotonda et al., 1996) .
Actin cleavage assay
Rabbit muscle actin was labeled with biotin by incubation with 100 mg/ml sulfosuccinimidyl-6-(biotinamido) hexanoate-biotin (Pierce, Rockfold, IL, USA) at 258C for 40 min in 0.1 M HEPES (pH 8.0). U937 cell lysates were resuspended in the suspension buer (Mashima et al., 1995b) , freezethawed four times and then centrifuged for 20 min at 70 000 g. The supernatant fractions were used for the following assay. The biotinylated actin (0.2 mg/assay) was incubated with the samples at 378C for 2 h in 20 mM HEPES (pH 7.5) 2 mM DTT, and 10% (v/v) glycerol (ICE assay buer), and then the reaction mixtures were separated by 15/25% gradient polyacrylamide gel (Daiichi Chemical, Tokyo, Japan). The electrophoresed proteins in the polyacrylamide gel were transblotted onto a nitrocellulose membrane. After blocking, the blotted nitrocellulose membrane was incubated with peroxidase-conjugated avidin (ABC Kit; Vector, Burlingame, CA, USA) at 258C for 1 h, washed several times with phosphate buer saline (PBS)-0.5% Tween 20, soaked in an enhanced chemiluminescence (ECL) mixture (Amersham, Buckinghamshire, United Kingdom), and exposed to Kodak X-Omat AR ®lm.
Anti-GQVIT antiserum
Rabbits were immunized eight times bi-weekly with synthetic GQVITC peptide conjugated to Keyhole Limpet Hemocyanin (Cosmo Bio Co, Ltd, Tokyo, Japan), and the antiserum was prepared (Saido et al., 1993) . The antibody was puri®ed by anity chromatography using GQVITC peptide coupled to FMP-cellulo®ne (Seikagaku Co, Tokyo, Japan).
Immunoprecipitation and Western blot assay
The immunoprecipitation study was performed as below. Anti-CPP-32 antibody was bound with protein A-agarose at 48C for 1 h in ICE assay buer. The antibody/protein A-agarose complex was then incubated with VP-16-treated U937 cell lysate (70 000 g sup.) at 48C for 1 h in ICE assay buer. After incubation, the fraction bound with the anti-CPP-32 antibody/protein A-agarose complex was precipitated by centrifugation at 15 000 g for 10 min, washed several times with ICE assay buer. The supernatant was collected as the immunoadsorbed supernatant. The Western blot assay using anti-CPP-32 and anti-Ich-1 L was performed as described previously (Noguchi et al., 1996) .
The Western blot assay using anti-actin (C4) and anti-GQVIT was performed as below. Cell lysates were separated by 15/25% gradient polyacrylamide gel and the electrophoresed proteins in the polyacrylamide gel were transblotted onto a nitrocellulose membrane. After blocking at room temperature for 1 h in blocking buer (PBS(7)-5% skim milk-0.1% Tween 20), the membrane was soaked at room temperature for 2 h in anti-actin (C4) antibody (at a 1 : 100 dilution in blocking buer) or in anti-GQVIT antiserm (at a 1 : 50 dilution in blocking buer), followed by three washes in PBS(7)-0.1% Tween 20 and incubation in anti-mouse Igperoxidase conjugated (in case of anti-C4 Western) or antirabbit Ig-peroxidase conjugated (in case of anti-GQVITC Western) at room temperature for 1 h. After several washes, the bands were visualized by ECL.
